1. Home
  2. QNCX vs FAT Comparison

QNCX vs FAT Comparison

Compare QNCX & FAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • FAT
  • Stock Information
  • Founded
  • QNCX 2012
  • FAT 2017
  • Country
  • QNCX United States
  • FAT United States
  • Employees
  • QNCX N/A
  • FAT N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • FAT Restaurants
  • Sector
  • QNCX Health Care
  • FAT Consumer Discretionary
  • Exchange
  • QNCX Nasdaq
  • FAT Nasdaq
  • Market Cap
  • QNCX 47.7M
  • FAT 44.0M
  • IPO Year
  • QNCX 2019
  • FAT 2017
  • Fundamental
  • Price
  • QNCX $1.68
  • FAT $2.40
  • Analyst Decision
  • QNCX Strong Buy
  • FAT Strong Buy
  • Analyst Count
  • QNCX 5
  • FAT 1
  • Target Price
  • QNCX $8.00
  • FAT $10.00
  • AVG Volume (30 Days)
  • QNCX 235.8K
  • FAT 42.0K
  • Earning Date
  • QNCX 08-12-2025
  • FAT 08-08-2025
  • Dividend Yield
  • QNCX N/A
  • FAT 11.67%
  • EPS Growth
  • QNCX N/A
  • FAT N/A
  • EPS
  • QNCX N/A
  • FAT N/A
  • Revenue
  • QNCX N/A
  • FAT $582,704,000.00
  • Revenue This Year
  • QNCX N/A
  • FAT N/A
  • Revenue Next Year
  • QNCX N/A
  • FAT $8.68
  • P/E Ratio
  • QNCX N/A
  • FAT N/A
  • Revenue Growth
  • QNCX N/A
  • FAT 10.63
  • 52 Week Low
  • QNCX $0.51
  • FAT $2.01
  • 52 Week High
  • QNCX $2.45
  • FAT $4.10
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 50.83
  • FAT 46.88
  • Support Level
  • QNCX $1.75
  • FAT $2.30
  • Resistance Level
  • QNCX $2.05
  • FAT $2.50
  • Average True Range (ATR)
  • QNCX 0.16
  • FAT 0.11
  • MACD
  • QNCX -0.02
  • FAT 0.00
  • Stochastic Oscillator
  • QNCX 9.76
  • FAT 33.33

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

About FAT FAT Brands Inc.

FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, acquires, and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts around the world. The company operates as a franchisor of restaurants, where the company generally does not own or operate the restaurant locations but rather generates revenue by charging franchisees an initial franchise fee as well as ongoing royalties. For some of the company's brands, it also directly owns and operates restaurant locations. Its brands include Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, and Elevation Burger among others. Geographically, the majority of the revenue for the company is generated from the United States.

Share on Social Networks: